Trinity Biotech specialises in the development, manufacture and marketing of diagnostic test kits. Their continued success is based on the fact, that as a company, they consistently achieve standards of excellence in the quality of all they do.

The test kits they manufacture are used in the clinical laboratory and point-of-care segments of the diagnostic market, to detect infectious diseases, sexually transmitted diseases, autoimmune disorders, cardiac arrest, haemoglobin disorders, and in the detection, monitoring and control of diabetes. They are also a significant provider of raw materials to the life sciences industry.

Quoted on the NASDAQ exchange, and with facilities spanning Europe and America, their products are sold in more than 110 countries. They reach their customers worldwide by combining the skills of our own sales force with a network of international distributors and strategic partners.

HISTORY

Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation.  Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products.

Today Trinity Biotech is listed on the NASDAQ Global Select Market, and has approximately 21 million American Depository Shares. The Company, which has its headquarters in Bray, Ireland, employs in excess of 570 people worldwide and markets its portfolio of over 400 products to customers in over 110 countries around the world.

VISION

Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. A combination of strong organic growth and a progressive acquisition-led strategy has seen the company assemble an impressive portfolio of over 400 products to date.

Specialising in the development, manufacture and marketing of diagnostic test kits, Trinity Biotech’s continued success is based on the fact that as a company it consistently achieves standards of excellence in the quality of all it does.